This study is looking at whether offering genetic testing for cancer risk is practical and accepted by women attending regular gynecology appointments. You would receive the Natera® Empower™ hereditary cancer panel test, which uses a saliva sample. If the test finds certain genetic changes that increase cancer risk, you would be referred to specialists like a medical oncologist or breast surgeon to discuss ways to reduce that risk, and offered genetic counseling. The study aims to see how many eligible women get tested and how many have these genetic changes. You can join if you are a woman between 25 and 39 years old and receive gynecologic care at an affiliated NYU Langone Health site. The study is currently recruiting.

Study design

This is an interventional study planning to enroll 600 women. It is not specified if it is randomized or blinded.

What's involved

You would provide a saliva sample for the Natera® Empower™ hereditary cancer panel test. If certain genetic changes are found, you would be referred to specialists and offered genetic counseling.

Compensation

Not stated in the trial record.

Follow-up

The primary endpoint, genetic testing, is measured up to 9 months.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.